Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y4AS
|
|||
| Former ID |
DIB019690
|
|||
| Drug Name |
DABCO
|
|||
| Synonyms |
1,4-Diazabicyclo[2.2.2]octane; Triethylenediamine; 280-57-9; Dabco; Dabco 33LV; 1,4-Ethylenepiperazine; 1,4-DIAZABICYCLO(2.2.2)OCTANE; Dabco crystal; TEDA; Texacat TD 100; N,N'-endo-Ethylenepiperazine; Dabco S-25; D 33LV; Dabco EG; 1,4-Diazabicyclo-octane; Dabco R-8020; 1,4-Diazobicyclo(2.2.2)octane; Thancat TD 33; Bicyclo(2,2,2)-1,4-diazaoctane; 1,4-diazabicyclooctane; 1,4-diazabicyclo[2,2,2]octane; 1,4-diaza-bicyclo[2.2.2]octane; UNII-X8M57R0JS5; NSC 56362; CCRIS 6692; TED; HSDB 5556; 1,4-Diaza[2.2.2]bicyclooctane; EINECS 205-999-9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C6H12N2
|
|||
| Canonical SMILES |
C1CN2CCN1CC2
|
|||
| InChI |
1S/C6H12N2/c1-2-8-5-3-7(1)4-6-8/h1-6H2
|
|||
| InChIKey |
IMNIMPAHZVJRPE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 280-57-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
105780, 591695, 3132693, 5167848, 8156597, 10516835, 15146452, 24857483, 24893714, 29227850, 48415208, 48417526, 49960758, 51073904, 57325516, 57654087, 79512663, 81053159, 85085297, 85085298, 87363649, 87566869, 92251788, 98461894, 104319966, 104667475, 117358268, 117670463, 117688822, 118309380, 124955246, 125346875, 126652775, 126677477, 127291552, 127291553, 127291554, 127291555, 127291556, 127291557, 127291558, 127291559, 127291560, 127291561, 127291562, 127291563, 127291564, 127291565, 127291566, 127291567
|
|||
| ChEBI ID |
CHEBI:151129
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated potassium channel Kv3.4 (KCNC4) | Target Info | Blocker (channel blocker) | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2577). | |||
| REF 2 | 1,4-Diazabicyclo[2.2.2]octane derivatives: a novel class of voltage-gated potassium channel blockers. Mol Pharmacol. 2006 Mar;69(3):718-26. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.